Pancreatic Cancer Research

ResearcherChanghai HospitalActive in the last 2 years

Peng Cheng

Provisional: name at one institution (moderate confidence, 0.60), identity_conf@1As of 7 November 2026

Known by name at one institution; no external author ID yet. Sources: OpenAlex.

Their work

Papers
2 (first author 0, last author 1)
Trials
0
Grants
0
Labs led
0
Collaborators
7
Papers, trials and grants by year

2019: 1 paper · 2020: none · 2021: none · 2022: none · 2023: none · 2024: none · 2025: 1 paper

Papers 2

  1. Menin regulates YBX1 nucleus translocation to boost the HKDC1 transcription and affects pancreatic cancer glycolysis. Last author DOI 10.1016/j.isci.2025.113245↗
  2. Menin Coordinates C/EBPβ-Mediated TGF-β Signaling for Epithelial-Mesenchymal Transition and Growth Inhibition in Pancreatic Cancer. Co-author DOI 10.1016/j.omtn.2019.08.013↗

Closest collaborators

The 7 strongest of 7 by collab_strength@1: shared papers, trials and grants, recent and small-team work weighing most.

  1. Chenming Ni · 2 shared papers, 2019–2025 · strength 0.34
  2. Tianlin He · 2 shared papers, 2019–2025 · strength 0.34
  3. Gang Jin · 2 shared papers, 2019–2025 · strength 0.34
  4. Yebin Lu · 1 shared paper, 2025 · strength 0.25
  5. Xiaohan Shi · 1 shared paper, 2025 · strength 0.25
  6. Shiwei Guo · 1 shared paper, 2019 · strength 0.10
  7. Yijie Zhang · 1 shared paper, 2019 · strength 0.10

How to reach this person

A chain of introductions through people who have published, run trials or held grants together (warm_path@1: fewest links first, then the strongest). Built from public records only; no contact details are kept.